nicola
pusterla
christian
leutenegg
readi
avail
correct
etiolog
diagnosi
particularli
set
contagi
infect
enabl
veterinarian
make
earli
decis
regard
patient
care
manag
address
appropri
treatment
effect
time
notif
discuss
manag
issu
pertain
prevent
diseas
spread
past
two
decad
seen
revolut
understand
manag
diagnosi
control
prevent
infecti
diseas
period
encompass
discoveri
emerg
equin
agent
antimicrobi
vaccin
well
wealth
improv
diagnost
test
molecular
test
method
equin
practition
despit
advanc
infecti
diseas
remain
lead
caus
equin
morbid
mortal
resurg
certain
infect
increas
popul
elderli
suscept
hors
increas
level
intern
equin
commerc
expand
geograph
distribut
pathogen
focu
rapid
diagnosi
infecti
diseas
also
shift
time
obviou
chang
appear
increas
import
nucleic
acid
na
amplificationbas
techniqu
primarili
polymeras
chain
reaction
pcr
expens
tradit
method
clinic
microbiolog
polymeras
chain
reaction
becom
increasingli
import
tool
microbi
diagnosi
recent
year
rapid
afford
high
sensit
high
specif
characterist
propel
field
pcrbase
molecular
diagnost
arena
appli
diagnost
infecti
agent
number
publish
offer
pcr
assay
steadili
rise
need
critic
evalu
comparison
perform
eventu
also
standard
method
enabl
equin
practition
select
optim
methodolog
key
featur
adopt
molecular
diagnost
infecti
agent
superior
sensit
specif
compar
immunoassay
autom
platform
significantli
increas
throughput
quantit
assess
pathogen
load
clinic
use
fast
turnaround
time
speed
detect
reduc
overal
cost
simultan
analysi
multipl
analyt
mani
veterinarian
awar
avail
molecular
diagnost
test
use
techniqu
practic
howev
lack
market
domin
molecular
diagnost
rel
fragment
market
lead
confus
confus
mostli
base
lack
direct
educ
within
veterinari
commun
veterinarian
reli
continu
educ
offer
local
nation
meet
improv
knowledg
base
molecular
diagnost
practition
use
pcr
diagnos
infecti
diseas
understand
involv
process
import
indic
use
pcr
interpret
result
often
confus
warrant
educ
within
veterinari
commun
differ
among
laboratori
protocol
use
add
confus
caus
lack
accept
standard
parallel
test
multipl
infecti
agent
highli
standard
platform
central
compon
molecular
assay
essenti
allow
sever
detect
dna
rna
pathogen
target
happen
simultan
singl
sampl
develop
noteworthi
driver
molecular
diagnost
allow
acquisit
meaning
data
singl
sampl
socal
panel
strategi
enabl
effici
workup
complex
clinic
syndrom
gener
nonspecif
clinic
sign
clinic
situat
allow
easi
diagnost
decis
make
veterinarian
multipl
infecti
agent
respons
given
clinic
pictur
even
though
veterinarian
tend
make
singlepathogen
diagnosi
becom
evid
recent
year
mani
syndrom
caus
coinfect
panel
test
larg
scale
uncov
unknown
dual
tripl
infect
anim
diffus
clinic
pictur
long
specul
seemingli
clinic
irrelev
equin
herpesviru
type
infect
hors
may
actual
aggrav
diffus
clinic
pictur
present
secondari
infect
characterist
exampl
known
companion
anim
respiratori
infect
often
initi
subclin
viru
infect
lead
way
secondari
infect
gener
molecular
diagnost
laboratori
provid
precis
recommend
sampl
collect
ship
instruct
pertain
specimen
type
volum
anticoagul
transport
specif
storag
handl
sampl
type
type
need
larg
influenc
pathogenesi
diseas
play
key
role
perform
interpret
test
result
veterinarian
advis
adher
recommend
qualiti
result
directli
correl
qualiti
sampl
preserv
nucleic
acid
content
whole
blood
sampl
collect
asept
evacu
blood
tube
contain
edta
bodi
fluid
eg
thorac
abdomin
joint
cerebrospin
tracheal
wash
bronchoalveolar
guttur
pouch
lavag
fluid
tissu
collect
serum
tube
without
addit
nasal
nasopharyng
secret
collect
rayonor
dacrontip
swab
best
kept
serum
conic
tube
fecal
materi
collect
small
fecal
cup
serum
tube
sampl
must
sent
cool
blue
ice
express
pcr
infecti
diseas
diagnosi
manag
mail
overnight
laboratori
freez
sampl
avoid
detriment
effect
thaw
process
na
shortterm
storag
period
day
shipment
would
necessari
weekend
done
refriger
compart
sampl
properli
label
accompani
submiss
form
contain
inform
anim
owner
veterinarian
sampl
suspect
pathogen
submiss
form
download
respect
laboratori
websit
laboratori
notifi
advanc
inquiri
made
avail
offer
test
well
expect
turnaround
time
associ
cost
incom
sampl
normal
process
day
pcr
result
usual
avail
within
hour
includ
ship
purifi
na
pass
intern
sampl
qualiti
control
confirm
proper
collect
storag
ship
na
extract
associ
qualiti
control
pcrposit
pcrneg
control
intern
posit
control
confirm
absenc
pcr
inhibitor
neg
extract
control
confirm
absenc
crosscontamin
na
extract
process
veterinarian
awar
qualiti
control
run
diagnost
sampl
inquir
respect
diagnost
laboratori
interpret
result
obtain
molecular
assay
infecti
diseas
necessit
understand
pathogenesi
biolog
target
organ
challeng
uniqu
molecular
test
differ
consider
interpret
microbiolog
test
differ
relat
distinct
viabl
nonviabl
organ
correl
na
detect
presenc
diseas
diseas
associ
interpret
neg
result
requir
take
consider
inform
sensit
pcr
test
limit
detect
na
extract
effici
indic
use
quantit
intern
sampl
control
falseneg
result
may
caus
degrad
unstabl
sampl
insuffici
inappropri
sampl
type
inadequ
sampl
procedur
transport
problem
addit
sourc
falseneg
result
samplespecif
intern
posit
sampl
control
target
endogen
gene
univers
rrna
singlestrand
rrna
dehydrogenas
gapdh
gene
help
overcom
problem
particularli
lab
use
quantit
fashion
assess
quantiti
na
go
pcr
protocol
directli
influenc
limit
detect
assay
addit
inhibit
phenomena
origin
sampl
matrix
fece
urin
environment
sampl
contamin
soil
surfac
water
control
intern
posit
control
assess
inhibitori
effect
pcr
process
factor
consid
interpret
posit
result
includ
assay
specif
contamin
issu
polymeras
chain
reaction
target
amplif
method
subject
consider
realtim
pcr
closedtub
detect
procedur
reduc
risk
pcr
product
carryov
sourc
falseposit
result
gener
molecular
assay
provid
inform
viabil
infecti
agent
except
dna
virus
bacteria
parasit
analyz
presenc
rna
molecul
rrna
transcrib
gene
form
messeng
rna
instead
genom
dna
equival
target
splice
rna
occur
certain
step
replic
cycl
particular
virus
provid
addit
inform
replic
activ
viru
case
target
ribosom
rna
parasit
toxoplasma
spp
cryptosporidium
spp
mean
obtain
viabil
inform
also
may
increas
analyt
sensit
detect
pathogen
na
sampl
necessarili
indic
organ
caus
diseas
howev
use
quantit
inform
realtim
pcr
result
may
give
insight
provid
mean
evalu
diseas
associ
primari
exampl
herpesviru
infect
quantit
detect
dna
may
indic
presenc
lytic
nonrepl
latent
viru
studi
indic
high
viral
load
dna
allow
formul
laboratoryspecif
cutoff
valu
differenti
lytic
nonrepl
viru
case
high
viral
load
gener
associ
presenc
clinic
sign
presenc
viral
rna
transcript
indic
viru
replic
therefor
quantit
realtim
pcr
provid
mean
obtain
inform
diseas
associ
crucial
criterion
equin
practition
make
correct
diagnosi
veterinarian
use
varieti
guidelin
select
laboratori
molecular
diagnost
test
certain
question
worth
ask
sampl
submit
molecular
diagnost
laboratori
question
cover
three
area
first
worthwhil
obtain
inform
natur
pcr
test
platform
tradit
versu
realtim
second
question
ask
qualiti
control
qualiti
assur
system
within
particular
laboratori
particular
use
know
whether
whole
process
control
singl
point
control
use
contamin
avoid
confirm
absent
within
laboratori
third
addit
question
turnaround
time
price
level
guidanc
result
interpret
worth
ask
sampl
submit
facilit
decis
pathogen
evalu
specif
case
mani
modern
molecular
laboratori
offer
panel
cover
specif
organ
system
eg
respiratori
gastrointestin
nervou
system
panel
test
sever
common
pathogen
organ
system
diagnost
pcr
applic
relev
equin
practic
summar
tabl
despit
intens
investig
effort
veterinarian
frequent
diagnos
clinic
infecti
respiratori
tract
diseas
without
identifi
primari
etiolog
agent
recent
voluntari
surveil
studi
equid
unit
state
clinic
sign
acuteonset
respiratori
tract
infect
determin
index
case
posit
pcr
result
one
four
select
common
respiratori
pathogen
equin
influenza
viru
eiv
streptococcu
equi
subsp
equi
highest
detect
rate
follow
eiv
equi
equi
absenc
etiolog
diagnosi
infecti
respiratori
tract
diseas
case
observ
studi
least
partial
attribut
concentr
diagnost
effort
identifi
infect
agent
frequent
caus
diseas
like
comprehens
diagnost
effort
would
identifi
agent
affect
anim
tend
caus
either
less
dramat
outbreak
sporad
rather
epidem
diseas
eg
equin
rhiniti
virus
nasopharyng
swab
collect
earli
febril
phase
diseas
lymphotrop
detect
also
attempt
whole
blood
pcr
assay
use
diagnost
field
base
detect
viral
genom
dna
therefor
unabl
distinguish
lytic
dead
latent
viru
altern
molecular
approach
recent
establish
use
quantit
realtim
pcr
allow
discrimin
differ
viral
state
hors
natur
infect
ehv
discrimin
differ
viral
state
possibl
target
sever
gene
eg
glycoprotein
latencyassoci
transcript
detect
viral
genom
dna
transcript
activ
target
gene
messeng
rna
level
use
absolut
viru
quantif
quantit
threshold
use
select
human
infecti
diseas
eg
human
immunodefici
viru
hepat
c
viru
herp
simplex
viru
determin
diseas
stage
respons
antivir
therapi
similar
concept
use
diagnost
hors
discrimin
lytic
nonrepl
virus
determin
infecti
risk
base
viral
load
nasal
secret
monitor
respons
treatment
streptococcu
equi
subsp
equi
infect
rare
associ
detect
difficulti
convent
cultur
use
clinic
affect
hors
see
also
chapter
cultur
nasal
swab
nasopharyng
guttur
pouch
wash
exud
aspir
abscess
remain
gold
standard
detect
equi
equi
cultur
howev
may
unsuccess
incub
earli
clinic
phase
infect
presenc
streptococci
especi
equi
subsp
zooepidemicu
may
complic
interpret
cultur
avail
pcr
assay
design
detect
dna
sequenc
equi
protein
sem
gene
code
organ
antiphagocyt
protein
gene
offer
suffici
nucleotid
variabl
two
equi
subspeci
allow
full
discrimin
clinic
specimen
one
pitfal
pcr
inabl
distinguish
viabl
nonviabl
organ
therefor
posit
result
consid
presumpt
past
confirm
cultur
present
question
viabil
address
quantit
sem
gene
detect
transcript
activ
sem
gene
rna
level
sever
studi
pcr
prove
much
three
time
sensit
cultur
use
pcr
accompani
cultur
nasal
swab
guttur
pouch
lavag
sampl
may
advantag
control
program
select
possibl
carrier
anim
pcr
capabl
detect
equi
dna
guttur
pouch
fluid
week
disappear
live
organ
case
nasopharynx
effici
mucociliari
apparatu
remov
organ
dna
time
use
pcr
consid
detect
asymptomat
carrier
establish
equi
infect
statu
asymptomat
hors
determin
success
elimin
equi
guttur
pouch
unfortun
diagnost
pcr
assay
unabl
differenti
wildtyp
nonencapsul
avirul
vaccin
strain
equi
howev
necessari
forens
reason
differenti
undertaken
basi
morpholog
coloni
biochem
analysi
genotyp
restrict
digest
togeth
assay
allow
differenti
wildtyp
vaccin
ancestor
strain
sampl
choic
molecular
detect
virus
associ
infecti
respiratori
tract
diseas
nasal
secret
gener
collect
nasal
passag
nasopharynx
use
rayonor
dacrontip
swab
use
viral
transport
medium
transport
nasal
swab
necessari
pcr
detect
nabas
assay
reli
viabil
target
pathogen
polymeras
chain
reaction
assay
test
presenc
eiv
equi
equi
superior
sensit
compar
antigencaptur
enzymelink
immunosorb
assay
elisa
convent
cultur
system
anoth
advantag
molecular
assay
abil
detect
nonviabl
viru
situat
may
occur
nasal
nasopharyng
sampl
frozen
adequ
store
ship
diagnost
laboratori
novel
pcr
platform
allow
quantit
dna
rna
content
given
sampl
interest
assess
kinet
viral
shed
determin
infecti
natur
clinic
subclin
infect
hors
assess
respons
treatment
equin
influenza
viru
routin
detect
nasal
secret
collect
hors
earli
febril
stage
diseas
see
also
chapter
amplif
singlestrand
rna
eiv
perform
revers
transcriptas
pcr
rtpcr
technolog
use
either
onestep
nest
realtim
approach
hemagglutinin
nucleoprotein
matrix
gene
commonli
target
gene
molecular
assay
nucleotid
deduc
amino
acid
sequenc
portion
hemagglutinin
gene
routin
use
phylogenet
character
outbreak
strain
equin
herpesviru
type
doublestrand
dna
infect
equin
respiratori
tract
establish
lifelong
latent
infect
exposur
see
also
chapter
diagnost
sampl
choic
nasal
neorickettsia
risticii
agent
potomac
hors
fever
phf
caus
seriou
enterocol
hors
age
diagnosi
phf
base
detect
n
risticii
blood
fece
infect
hors
isol
agent
cell
cultur
although
possibl
time
consum
routin
avail
mani
diagnost
laboratori
develop
n
risticiispecif
pcr
assay
greatli
facilit
diagnosi
phf
molecular
assay
key
investig
epidemiolog
phf
allow
discoveri
helminth
vector
intermedi
definit
helminth
host
well
determin
natur
rout
infect
although
na
n
risticii
detect
blood
fece
natur
experiment
infect
hors
detect
period
necessarili
coincid
two
sampl
type
therefor
recommend
analyz
type
biolog
sampl
hors
suspect
phf
enhanc
chanc
molecular
detect
n
risticii
lawsonia
intracellulari
agent
equin
prolif
enteropathi
epe
emerg
equin
gastrointestin
pathogen
young
hors
see
also
chapter
cultur
l
intracellulari
fece
possibl
present
antemortem
diagnosi
reli
serolog
pcr
combin
test
increas
chanc
diagnos
epe
test
pcr
advantag
fast
abl
yield
posit
result
earli
stage
diseas
antibodi
yet
measur
prior
use
antimicrobi
neg
affect
molecular
detect
l
intracellulari
fece
therefor
suspect
case
fecal
collect
pcr
test
perform
initi
antimicrobi
treatment
recent
year
pcr
assay
detect
salmonella
spp
fecal
sampl
hors
admit
veterinari
hospit
evalu
collect
studi
unquestion
report
higher
analyt
sensit
detect
salmonella
spp
pcr
assay
compar
convent
microbiolog
cultur
higher
detect
rate
salmonella
pcr
attribut
detect
nonviabl
organ
previous
undescrib
salmonellalik
bacteri
organ
use
novel
virul
target
gene
molecular
detect
salmonella
consider
improv
perform
accuraci
assay
veterinari
hospit
north
america
switch
convent
microbiolog
cultur
pcr
salmonella
test
part
infecti
diseas
control
program
instanc
pcr
perform
fecal
environment
sampl
follow
select
enrich
step
use
pcr
cost
effect
potenti
reduc
contamin
risk
turnaround
time
result
avail
hour
sampl
collect
eg
hour
enrich
time
plu
hour
dna
purif
amplif
use
absolut
quantit
allow
assess
infecti
natur
hospit
anim
may
excel
altern
convent
cultur
method
surveil
research
studi
detect
equin
coronaviru
ecov
pcr
fece
foal
fever
diarrhea
difficult
interpret
ecov
also
detect
fece
healthi
foal
healthi
foal
found
infect
ecov
singl
infect
without
coinfect
agent
wherea
ecov
sick
foal
found
exclus
associ
coinfect
agent
find
agreement
behavior
coronavirus
speci
viru
may
enough
pathogen
potenti
caus
diseas
caus
local
immun
equin
rhiniti
b
viru
see
also
chapter
equin
arter
viru
although
less
commonli
associ
infecti
upper
respiratori
tract
diseas
also
consid
target
pathogen
respiratori
outbreak
role
nasal
secret
hors
infecti
respiratori
diseas
still
unclear
given
high
preval
hors
popul
order
avoid
dilemma
interpret
pcr
result
test
recommend
present
although
highli
sensit
specif
pcr
assay
develop
detect
viral
protozo
pathogen
cerebrospin
fluid
csf
neurolog
hors
method
often
limit
valu
routin
diagnosi
either
viremia
short
live
pathogen
affin
nucleat
cell
csf
consequ
pathogen
usual
longer
detect
onset
system
neurolog
sign
one
except
uncommon
neurolog
form
infect
known
equin
herpesviru
myeloencephalopathi
ehm
diagnosi
ehm
support
histor
clinic
find
see
also
chapter
presenc
xanthochromia
high
total
protein
concentr
csf
laboratori
detect
blood
nasal
secret
pcr
affect
hors
shed
viru
nasal
secret
thu
repres
risk
infect
unaffect
incontact
hors
imper
determin
risk
shed
suspect
hors
initi
appropri
infecti
diseas
control
protocol
dilemma
whether
viru
lytic
nonrepl
latent
state
address
use
absolut
quantit
transcript
activ
target
gene
similar
approach
use
research
group
recent
identifi
region
variat
genom
differ
strain
neuropathogen
vs
nonneuropathogen
singl
nucleotid
polymorph
posit
dna
polymeras
gene
orf
associ
higher
risk
ehm
develop
rapid
pcr
assay
establish
allow
differenti
neuropathogen
nonneuropathogen
strain
howev
assay
moder
specif
strain
associ
ehm
neuropathogen
genotyp
therefor
assay
use
judici
result
alway
interpret
context
clinic
present
assay
coupl
addit
assay
target
conserv
region
genom
detect
equin
gastrointestin
pathogen
convent
molecular
test
challeng
pathogen
either
difficult
grow
cell
cultur
system
present
pathogen
nonpathogen
form
make
interpret
posit
result
difficult
furthermor
use
fecal
materi
molecular
diagnost
associ
falseneg
result
inhibitori
substanc
fece
interfer
na
extract
amplif
howev
develop
use
specif
extract
kit
deriv
set
appropri
control
intern
posit
control
improv
yield
qualiti
na
fece
expand
usabl
molecular
method
biolog
sampl
type
import
sampl
qualiti
inhibit
monitor
intern
extern
control
addit
pcr
assay
borrelia
burgdorferi
sensu
lato
leptospira
spp
mycobacterium
spp
mycoplasma
spp
babesia
cabal
theileria
equi
clostridium
difficil
antigen
toxin
b
toxigen
clostridium
perfringen
cryptosporidium
spp
methicillinresist
staphylococcu
aureu
develop
use
research
set
assay
like
offer
near
futur
diagnost
purpos
addit
epidemiolog
inform
accuraci
test
valid
clinic
sampl
infect
hors
suppress
enabl
secondari
infect
becom
establish
effici
adult
hors
ecov
caus
selflimit
diseas
character
depress
inappet
fever
less
frequent
chang
fecal
charact
colic
epidemiolog
studi
need
better
understand
impact
emerg
diseas
equin
rotaviru
pose
challeng
foal
season
farm
manag
veterinarian
intens
hors
breed
area
throughout
world
quick
reliabl
diagnosi
essenti
separ
affect
foal
diarrhea
reduc
spread
viru
diagnosi
rotaviru
infect
past
reli
direct
viru
detect
rapid
antigencaptur
elisa
recent
develop
pcr
assay
high
analyt
sensit
specif
accuraci
diagnosi
equin
rotaviru
infect
like
replac
less
sensit
elisa
test
near
futur
equin
granulocyt
anaplasmosi
caus
anaplasma
phagocytophilum
rickettsi
pathogen
transmit
ixod
spp
tick
diagnosi
often
base
awar
geograph
area
infect
typic
clinic
sign
abnorm
laboratori
find
identifi
characterist
pathogen
inclus
cytoplasm
neutrophil
eosinophil
peripher
blood
smear
polymeras
chain
reaction
use
mani
year
studi
aspect
epidemiolog
pathophysiolog
equin
granulocyt
anaplasmosi
clinic
purpos
materi
choic
whole
blood
pcr
sensit
specif
tool
support
diagnosi
especi
earli
late
stage
diseas
number
organ
small
detect
microscopi
corynebacterium
pseudotuberculosi
common
caus
extern
intern
abscess
hors
arid
region
north
america
epidemiolog
recent
investig
help
pcr
fli
identifi
mechan
vector
c
pseudotuberculosi
easi
grow
cultur
indic
pcr
restrict
specif
situat
eg
aspir
bodi
fluid
cultur
neg
